267
Views
43
CrossRef citations to date
0
Altmetric
Review

An integrated perspective on diabetic, alcoholic, and drug-induced neuropathy, etiology, and treatment in the US

, &
Pages 219-228 | Published online: 20 Jan 2017

References

  • JensenTSBaronRHaanpääMA new definition of neuropathic painPain2011152102204220521764514
  • GustorffBDornerTLikarRPrevalence of self-reported neuropathic pain and impact on quality of life: a prospective representative surveyActa Anaesthesiol Scand200852113213617976220
  • BouhassiraDLanteri-MinetMAttalNLaurentBTouboulCPrevalence of chronic pain with neuropathic characteristics in the general populationPain2008136338038717888574
  • TorranceNSmithBHBennettMILeeAJThe epidemiology of chronic pain of predominantly neuropathic origin: results from a general population surveyJ Pain20067428128916618472
  • van HeckeOAustinSKKhanRASmithBHTorranceNNeuropathic pain in the general population: a systematic review of epidemiological studiesPain2014155465466224291734
  • BaronRForsterMBinderASubgrouping of patients with neuropathic pain according to pain-related sensory abnormalities: a first step to a stratified treatment approachLancet Neurol20121111999100523079556
  • MenkeACasagrandeSGeissLCowieCCPrevalence of and trends in diabetes among adults in the United States, 1988–2012JAMA2015314101021102926348752
  • American Diabetes Association Available from: http://diabetes.org/Accessed January 13, 2017
  • AmmendolaATataMRAurilioCPeripheral neuropathy in chronic alcoholism: a retrospective cross-sectional study in 76 subjectsAlcohol Alcohol200136327127511373267
  • LoprinziCLReevesBNDakhilSRNatural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1J Clin Oncol201129111472147821383290
  • BeissnerFBrandauAHenkeCQuick discrimination of Adelta and C fiber mediated pain based on three verbal descriptorsPloS One201059e1294420886070
  • McGloneFReillyDThe cutaneous sensory systemNeurosci Biobehav Rev201034214815919712693
  • HoitsmaEReulenJPde BaetsMDrentMSpaansFFaberCGSmall fiber neuropathy: a common and important clinical disorderJ Neurol Sci2004227111913015546602
  • LefaucheurJPCreangeANeurophysiological testing correlates with clinical examination according to fibre type involvement and severity in sensory neuropathyJ Neurol Neurosurg Psychiatry200475341742214966158
  • LauriaGMorbinMLombardiRAxonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathiesNeurology200361563163612963753
  • MagerlWAliZEllrichJMeyerRATreedeRDC- and Aδ-fiber components of heat-evoked cerebral potentials in healthy human subjectsPain199982212713710467918
  • TreedeRDLorenzJBaumgartnerUClinical usefulness of laser-evoked potentialsNeurophysiol Clin200333630331414678844
  • GranovskyYMatreDSokolikALorenzJCaseyKLThermoreceptive innervation of human glabrous and hairy skin: a contact heat evoked potential analysisPain2005115323824715911150
  • ChenACNiddamDMArendt-NielsenLContact heat evoked potentials as a valid means to study nociceptive pathways in human subjectsNeurosci Lett20013162798211742720
  • BreinerALovblomLEPerkinsBABrilVDoes the prevailing hypothesis that small-fiber dysfunction precedes large-fiber dysfunction apply to type 1 diabetic patients?Diabetes Care20143751418142424574353
  • EnglandJDGronsethGSFranklinGDistal symmetric polyneuropathy: a definition for clinical researchNeurology200564219920715668414
  • RushAMCumminsTRWaxmanSGMultiple sodium channels and their roles in electrogenesis within dorsal root ganglion neuronsJ Physiol2007579Pt 111417158175
  • WangWGuJLiYQTaoYXAre voltage-gated sodium channels on the dorsal root ganglion involved in the development of neuropathic pain?Mol Pain201171621345196
  • WoolfCJThompsonSWThe induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity statesPain19914432932991828878
  • UlteniusCLinderothBMeyersonBAWallinJSpinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the ratNeurosci Lett20063991–2859016469445
  • LuYSunYNWuXRole of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionate (AMPA) receptor subunit GluR1 in spinal dorsal horn in inflammatory nociception and neuropathic nociception in ratBrain Res20081200192618289517
  • ParkJSYasterMGuanXRole of spinal cord α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors in complete Freund’s adjuvant-induced inflammatory painMol Pain200846719116032
  • LatremoliereAWoolfCJCentral sensitization: a generator of pain hypersensitivity by central neural plasticityJ Pain200910989592619712899
  • JørumEWarnckeTStubhaugACold allodynia and hyperalgesia in neuropathic pain: the effect of N-methyl-D-aspartate (NMDA) receptor antagonist ketamine – a double-blind, cross-over comparison with alfentanil and placeboPain2003101322923512583865
  • ChizhBAGöhringMTrösterAQuarteyGKSchmelzMKoppertWEffects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteersBr J Anaesth200798224625417251214
  • Al-HasaniRBruchasMRMolecular mechanisms of opioid receptor-dependent signaling and behaviorAnesthesiology201111561363138122020140
  • GallagherHCGallagherRMButlerMBuggyDJHenmanMCVenlafaxine for neuropathic pain in adultsCochrane Database Syst Rev20158CD01109126298465
  • BasbaumAIFieldsHLEndogenous pain control systems: brainstem spinal pathways and endorphin circuitryAnnu Rev Neurosci198473093386143527
  • BennettMThe LANSS pain scale: the Leeds assessment of neuropathic symptoms and signsPain2001921–214715711323136
  • FreynhagenRBaronRGockelUTolleTRPainDetect: a new screening questionnaire to identify neuropathic components in patients with back painCurr Med Res Opin200622101911192017022849
  • SpalloneVMorgantiRD’AmatoCGrecoCCacciottiLMarfiaGAValidation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathyDiabet Med201229557858522023377
  • HawleyRJKurtzkeJFArmbrustmacherVWSainiNManzHThe course of alcoholic-nutritional peripheral neuropathyActa Neurol Scand19826655825896293240
  • BoultonAJVinikAIArezzoJCDiabetic neuropathies: a statement by the American Diabetes AssociationDiabetes Care200528495696215793206
  • DaviesMBrophySWilliamsRTaylorAThe prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetesDiabetes Care20062971518152216801572
  • DiBonaventuraMDCappelleriJCJoshiAVAssociation between pain severity and health care resource use, health status, productivity and related costs in painful diabetic peripheral neuropathy patientsPain Med201112579980721481171
  • SadoskyASchaeferCMannRBurden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional surveyDiabetes Metab Syndr Obes20136799223403729
  • OrstavikKNamerBSchmidtRAbnormal function of C-fibers in patients with diabetic neuropathyJ Neurosci20062644112871129417079656
  • PittengerGLRayMBurcusNIMcNultyPBastaBVinikAIIntraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patientsDiabetes Care20042781974197915277426
  • PolydefkisMHauerPShethSSirdofskyMGriffinJWMcArthurJCThe time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathyBrain2004127Pt 71606161515128618
  • SmithAGRamachandranPTrippSSingletonJREpidermal nerve innervation in impaired glucose tolerance and diabetes-associated neuropathyNeurology20015791701170411706115
  • ChaoCCTsengMTLinYJPathophysiology of neuropathic pain in type 2 diabetes: skin denervation and contact heat-evoked potentialsDiabetes Care201033122654265920841612
  • LøsethSStålbergEVLindalSOlsenEJordeRMellgrenSISmall and large fiber neuropathy in those with type 1 and type 2 diabetes: a 5-year follow-up studyJ Peripher Nerv Syst2016211152126663481
  • JagodicMMPathirathnaSNelsonMTCell-specific alterations of T-type calcium current in painful diabetic neuropathy enhance excitability of sensory neuronsJ Neurosci200727123305331617376991
  • GordoisAScuffhamPShearerAOglesbyATobianJAThe health care costs of diabetic peripheral neuropathy in the USDiabetes Care20032661790179512766111
  • Gordon SmithARobinson SingletonJIdiopathic neuropathy, prediabetes and the metabolic syndromeJ Neurol Sci20062421–291416448668
  • XuZZhangPLongLHeHZhangJSunSDiabetes mellitus in classical trigeminal neuralgia: a predisposing factor for its developmentClin Neurol Neurosurg2016151707227816028
  • GreenAQKrishnanSFinucaneFMRaymanGAltered C-fiber function as an indicator of early peripheral neuropathy in individuals with impaired glucose toleranceDiabetes Care201033117417620040675
  • EdwardsJLVincentAMChengHTFeldmanELDiabetic neuropathy: mechanisms to managementPharmacol Ther2008120113418616962
  • BrownleeMBiochemistry and molecular cell biology of diabetic complicationsNature2001414686581382011742414
  • ObrosovaIGDrelVRPacherPOxidative-nitrosative stress and poly(ADP-ribose) polymerase (PARP) activation in experimental diabetic neuropathy: the relation is revisitedDiabetes200554123435344116306359
  • SouthanGJSzaboCPoly(ADP-ribose) polymerase inhibitorsCurr Med Chem200310432134012570705
  • DuXMatsumuraTEdelsteinDInhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cellsJ Clin Invest200311271049105714523042
  • SorianoFGVirágLJagtapPDiabetic endothelial dysfunction: the role of poly(ADP-ribose) polymerase activationNat Med20017110811311135624
  • HaHCHesterLDSnyderSHPoly(ADP-ribose) polymerase-1 dependence of stress-induced transcription factors and associated gene expression in gliaProc Natl Acad Sci USA20029953270327511854472
  • IlnytskaOLyzogubovVVStevensMJPoly(ADP-ribose) polymerase inhibition alleviates experimental diabetic sensory neuropathyDiabetes20065561686169416731831
  • LiFDrelVRSzabóCStevensMJObrosovaIGLow-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathyDiabetes20055451514152215855340
  • ObrosovaIGLiFAbatanOIRole of poly(ADP-ribose) polymerase activation in diabetic neuropathyDiabetes200453371172014988256
  • PacherPLiaudetLSorianoFGMableyJGSzabóESzabóCThe role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetesDiabetes200251251452111812763
  • ZhengLSzaboCKernTSPoly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-κBDiabetes200453112960296715504977
  • AbeTItokawaYEffect of ethanol administration on thiamine metabolism and transketolase activity in ratsInt J Vitam Nutr Res1977474307314591201
  • FrankOLuisada-OpperASorrellMFThomsonADBakerHVitamin deficits in severe alcoholic fatty liver of man calculated from multiple reference unitsExp Mol Pathol19711521911975111801
  • HoyumpaAMJrMechanisms of thiamin deficiency in chronic alcoholismAm J Clin Nutr19803312275027616254354
  • LeevyCMBakerHTenhoveWFrankOCherrickGRB-complex vitamins in liver disease of the alcoholicAm J Clin Nutr196516433934614278632
  • TomasuloPAKaterRMIberFLImpairment of thiamine absorption in alcoholismAm J Clin Nutr19682111134113445699730
  • KoikeHMoriKMisuKPainful alcoholic polyneuropathy with predominant small-fiber loss and normal thiamine statusNeurology200156121727173211425941
  • KoikeHIijimaMSugiuraMAlcoholic neuropathy is clinicopathologically distinct from thiamine-deficiency neuropathyAnn Neurol2003541192912838517
  • ChenXLevineJDMechanically-evoked C-fiber activity in painful alcohol and AIDS therapy neuropathy in the ratMol Pain20073517319957
  • ChopraKTiwariVAlcoholic neuropathy: possible mechanisms and future treatment possibilitiesBr J Clin Pharmacol201273334836221988193
  • NaritaMMiyoshiKSuzukiTInvolvement of microglia in the ethanol-induced neuropathic pain-like state in the ratNeurosci Lett20074141212517284346
  • MiyoshiKNaritaMTakatsuMSuzukiTmGlu5 receptor and protein kinase C implicated in the development and induction of neuropathic pain following chronic ethanol consumptionEur J Pharmacol2007562320821117349994
  • McDonoughKHAntioxidant nutrients and alcoholToxicology20031891–2899712821285
  • DinaOABarlettaJChenXKey role for the epsilon isoform of protein kinase C in painful alcoholic neuropathy in the ratJ Neurosci200020228614861911069970
  • DinaOAGearRWMessingROLevineJDSeverity of alcohol-induced painful peripheral neuropathy in female rats: role of estrogen and protein kinase (A and Cε)Neuroscience2007145135035617204374
  • JungMEGatchMBSimpkinsJWEstrogen neuroprotection against the neurotoxic effects of ethanol withdrawal: potential mechanismsExp Biol Med (Maywood)2005230182215618121
  • ChenCHFerreiraJCGrossERMochly-RosenDTargeting aldehyde dehydrogenase 2: new therapeutic opportunitiesPhysiol Rev201494113424382882
  • RöyttäMHorwitzSBRaineCSTaxol-induced neuropathy: short-term effects of local injectionJ Neurocytol19841356857016150968
  • RöyttäMRaineCSTaxol-induced neuropathy: chronic effects of local injectionJ Neurocytol19861544834962427662
  • VuorinenVRoyttaMRaineCSThe acute effects of taxol upon regenerating axons after nerve crushActa Neuropathol198876126342899374
  • VuorinenVRoyttaMRaineCSThe acute response of Schwann cells to taxol after nerve crushActa Neuropathol198876117252899373
  • PolomanoRCMannesAJClarkUSBennettGJA painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxelPain200194329330411731066
  • LiptonRBApfelSCDutcherJPTaxol produces a predominantly sensory neuropathyNeurology19893933683732564647
  • XiaoWHBennettGJChemotherapy-evoked neuropathic pain: abnormal spontaneous discharge in A-fiber and C-fiber primary afferent neurons and its suppression by acetyl-L-carnitinePain2008135326227017659836
  • CataJPWengHRBurtonAWVillarealHGiraltSDoughertyPMQuantitative sensory findings in patients with bortezomib-induced painJ Pain20078429630617175202
  • FlattersSJBennettGJStudies of peripheral sensory nerves in paclitaxel-induced painful peripheral neuropathy: evidence for mitochondrial dysfunctionPain2006122324525716530964
  • PostmaTJVermorkenJBLieftingAJPinedoHMHeimansJJPaclitaxel-induced neuropathyAnn Oncol1995654894947669713
  • KusTAktasGKalenderMETaxane-induced peripheral sensorial neuropathy in cancer patients is associated with duration of diabetes mellitus: a single-center retrospective studySupport Care Cancer20162431175117926279147
  • SmithEMPangHCirrincioneCEffect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trialJAMA2013309131359136723549581
  • GaistDJeppesenUAndersenMRodriguezLAHallasJSindrupSHStatins and risk of polyneuropathy: a case-control studyNeurology20025891333133712011277
  • LoYLLeohTHLohLMTanCEStatin therapy and small fibre neuropathy: a serial electrophysiological studyJ Neurol Sci20032081–210510812639733
  • BhallaSSinghNJaggiASStatins: do they aggravate or ameliorate neuropathic pain?J Pain201415111069108025086324
  • PathakNNBalaganurVLingarajuMCAtorvastatin attenuates neuropathic pain in rat neuropathy model by down-regulating oxidative damage at peripheral, spinal and supraspinal levelsNeurochem Int2014681924513038
  • Hernandez-OjedaJRoman-PintosLMRodriguez-CarrizalezADEffect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled Phase IIA studyDiabetes Metab Syndr Obes2014740140725214797
  • FinnerupNBAttalNHaroutounianSPharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysisLancet Neurol201514216217325575710
  • BoyleJErikssonMEGribbleLRandomized, placebo-controlled comparison of amitriptyline, duloxetine, and pregabalin in patients with chronic diabetic peripheral neuropathic pain: impact on pain, polysomnographic sleep, daytime functioning, and quality of lifeDiabetes Care201235122451245822991449
  • JoseVMBhansaliAHotaDPandhiPRandomized double-blind study comparing the efficacy and safety of lamotrigine and amitriptyline in painful diabetic neuropathyDiabet Med200724437738317335465
  • MaxMBCulnaneMSchaferSCAmitriptyline relieves diabetic neuropathy pain in patients with normal or depressed moodNeurology19873745895962436092
  • SindrupSHEjlertsenBFrølandASindrupEHBrøsenKGramLFImipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve functionEur J Clin Pharmacol19893721511532792168
  • SindrupSHOttoMFinnerupNBJensenTSAntidepressants in the treatment of neuropathic painBasic Clin Pharmacol Toxicol200596639940915910402
  • MooreRADerrySAldingtonDColePWiffenPJAmitriptyline for neuropathic pain and fibromyalgia in adultsCochrane Database Syst Rev20157CD008242
  • DerrySWiffenPJAldingtonDMooreRANortriptyline for neuropathic pain in adultsCochrane Database Syst Rev20151CD01120925569864
  • BasbaumAIBautistaDMScherrerGJuliusDCellular and molecular mechanisms of painCell2009139226728419837031
  • JuliusDBasbaumAIMolecular mechanisms of nociceptionNature2001413685220321011557989
  • BasbaumAISpinal mechanisms of acute and persistent painReg Anesth Pain Med199924159679952097
  • IyengarSWebsterAAHemrick-LueckeSKXuJYSimmonsRMEfficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in ratsJ Pharmacol Exp Ther2004311257658415254142
  • ArnoldLMLuYCroffordLJA double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis Rheum20045092974298415457467
  • ArnoldLMPritchettYLD’SouzaDNKajdaszDKIyengarSWernickeJFDuloxetine for the treatment of fibromyalgia in women: pooled results from two randomized, placebo-controlled clinical trialsJ Womens Health (Larchmt)20071681145115617937567
  • FishbainDADetkeMJWernickeJChappellASKajdaszDKThe relationship between antidepressant and analgesic responses: findings from six placebo-controlled trials assessing the efficacy of duloxetine in patients with major depressive disorderCurr Med Res Opin200824113105311518828958
  • GendreauRMThornMDGendreauJFEfficacy of milnacipran in patients with fibromyalgiaJ Rheumatol200532101975198516206355
  • MarksDMShahMJPatkarAAMasandPSParkGYPaeCUSerotonin-norepinephrine reuptake inhibitors for pain control: premise and promiseCurr Neuropharmacol20097433133620514212
  • RowbothamMCGoliVKunzNRLeiDVenlafaxine extended release in the treatment of painful diabetic neuropathy: a double-blind, placebo-controlled studyPain2004110369770615288411
  • NeilMJClonidine: clinical pharmacology and therapeutic use in pain managementCurr Clin Pharmacol20116428028721827389
  • LunnMPHughesRAWiffenPJDuloxetine for treating painful neuropathy, chronic pain or fibromyalgiaCochrane Database Syst Rev20141CD00711524385423
  • MatthewsEADickensonAHEffects of spinally delivered N- and P-type voltage-dependent calcium channel antagonists on dorsal horn neuronal responses in a rat model of neuropathyPain2001921–223524611323145
  • KatoAOhkuboTKitamuraKAlgogen-specific pain processing in mouse spinal cord: differential involvement of voltage-dependent Ca(2+) channels in synaptic transmissionBr J Pharmacol200213551336134211877344
  • WoolfCJSalterMWNeuronal plasticity: increasing the gain in painScience200028854721765176910846153
  • RumoreMMAronSMHirossEJA review of mechanism of action of aspirin and its potential as an immunomodulating agentMed Hypotheses19872243874002438544
  • BauerCSNieto-RostroMRahmanWThe increased trafficking of the calcium channel subunit α2δ-1 to presynaptic terminals in neuropathic pain is inhibited by the α2δ ligand pregabalinJ Neurosci200929134076408819339603
  • LuoZDChaplanSRHigueraESUpregulation of dorsal root ganglion α2δ calcium channel subunit and its correlation with allodynia in spinal nerve-injured ratsJ Neurosci20012161868187511245671
  • LiCYSongYHHigueraESLuoZDSpinal dorsal horn calcium channel α2δ-1 subunit upregulation contributes to peripheral nerve injury-induced tactile allodyniaJ Neurosci200424398494849915456823
  • BoroujerdiAKimHKLyuYSInjury discharges regulate calcium channel alpha-2-delta-1 subunit upregulation in the dorsal horn that contributes to initiation of neuropathic painPain2008139235836618571852
  • MaraisEKlugbauerNHofmannFCalcium channel α2δ subunits-structure and gabapentin bindingMol Pharmacol20015951243124811306709
  • MooreRAStraubeSWiffenPJDerrySMcQuayHJPregabalin for acute and chronic pain in adultsCochrane Database Syst Rev20093CD00707619588419
  • DonvitoGWilkersonJLDamajMILichtmanAHPalmitoylethanolamide reverses paclitaxel-induced allodynia in miceJ Pharmacol Exp Ther2016359231031827608657
  • MooreRAWiffenPJDerrySToelleTRiceASGabapentin for chronic neuropathic pain and fibromyalgia in adultsCochrane Database Syst Rev20144CD00793824771480
  • McGivernJGZiconotide: a review of its pharmacology and use in the treatment of painNeuropsychiat Dis Treat2007316985
  • PopeJEDeerTRBruelBMFalowskiSClinical uses of intrathecal therapy and its placement in the pain care algorithmPain Pract Epub2016223
  • McDowellGC2ndPopeJEIntrathecal ziconotide: dosing and administration strategies in patients with refractory chronic painNeuromodulation201619552253226856969
  • SanfordMIntrathecal ziconotide: a review of its use in patients with chronic pain refractory to other systemic or intrathecal analgesicsCNS Drugs20132711989100223999971
  • HayekSMHanesMCIntrathecal therapy for chronic pain: current trends and future needsCurr Pain Headache Rep201418138824338701
  • LaursenLPalliative care: the other opioid issueNature20165357611S16S1727410527
  • SchepersRJMahoneyJLShippenbergTSInflammation-induced changes in rostral ventromedial medulla mu and kappa opioid receptor mediated antinociceptionPain2008136332033017764840
  • HurleyRWHammondDLThe analgesic effects of supraspinal μ and δ opioid receptor agonists are potentiated during persistent inflammationJ Neurosci20002031249125910648729
  • FieldsHState-dependent opioid control of painNat Rev Neurosci20045756557515208698
  • SteinCSchaferMMachelskaHAttacking pain at its source: new perspectives on opioidsNat Med2003981003100812894165
  • VanderahTWDelta and kappa opioid receptors as suitable drug targets for painClin J Pain201026Suppl 10S10S1520026960
  • MaFXieHDongZQWangYQWuGCExpression of ORL1 mRNA in some brain nuclei in neuropathic pain ratsBrain Res200510431–221421715862535
  • ChenYSommerCNociceptin and its receptor in rat dorsal root ganglion neurons in neuropathic and inflammatory pain models: implications on pain processingJ Peripher Nerv Syst200611323224016930285
  • KabliNCahillCMAnti-allodynic effects of peripheral delta opioid receptors in neuropathic painPain20071271–2849316963185
  • BrisciniLCorradiniLOnginiEBertorelliRUp-regulation of ORL-1 receptors in spinal tissue of allodynic rats after sciatic nerve injuryEur J Pharmacol20024471596512106803
  • SunRQWangYZhaoCSChangJKHanJSChanges in brain content of nociceptin/orphanin FQ and endomorphin 2 in a rat model of neuropathic painNeurosci Lett20013111131611585556
  • NadalXBanosJEKiefferBLMaldonadoRNeuropathic pain is enhanced in δ-opioid receptor knockout miceEur J Neurosci200623383083416487163
  • AitaMByersMRChavkinCXuMTrigeminal injury causes kappa opioid-dependent allodynic, glial and immune cell responses in miceMol Pain20106820109235
  • ObaraIMikaJSchaferMKPrzewlockaBAntagonists of the κ-opioid receptor enhance allodynia in rats and mice after sciatic nerve ligationBr J Pharmacol2003140353854612970097
  • XuMPetraschkaMMcLaughlinJPNeuropathic pain activates the endogenous κ opioid system in mouse spinal cord and induces opioid receptor toleranceJ Neurosci200424194576458415140929
  • MikaJPrzewlockiRPrzewlockaBThe role of δ-opioid receptor subtypes in neuropathic painEur J Pharmacol20014151313711245849
  • PetrilloPAngeliciOBinghamSEvidence for a selective role of the δ-opioid agonist [8R-(4bS*,8aα,8aβ,12bβ)]7,10-Dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexa-hydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responsesJ Pharmacol Exp Ther200330731079108914551288
  • AbrahamKEBrewerKLMcGintyJFOpioid peptide messenger RNA expression is increased at spinal and supraspinal levels following excitotoxic spinal cord injuryNeuroscience200099118919710924963
  • AkbarSSubhanFKarimN6-Methoxyflavanone attenuates mechanical allodynia and vulvodynia in the streptozotocin-induced diabetic neuropathic painBiomed Pharmacother20168496297127764759
  • MogilJSGriselJEZhangsGBelknapJKGrandyDKFunctional antagonism of μ-, δ- and κ-opioid antinociception by orphanin FQNeurosci Lett19962142–31311348878101
  • MabuchiTMatsumuraSOkuda-AshitakaEAttenuation of neuropathic pain by the nociceptin/orphanin FQ antagonist JTC-801 is mediated by inhibition of nitric oxide productionEur J Neurosci20031771384139212713641
  • ScotoGMAricoGIemoloARonsisvalleSParentiCInvolvement of the nociceptin/orphanin FQ-NOP receptor system in the ventrolateral periaqueductal gray following mechanical allodynia in chronic painLife Sci2009855–620621019523963
  • SchieneKTzschentkeTMSchröderWChristophTMechanical hyperalgesia in rats with diabetic polyneuropathy is selectively inhibited by local peripheral nociceptin/orphanin FQ receptor and μ-opioid receptor agonismEur J Pharmacol2015754616525697471
  • DingHHayashidaKSutoTSupraspinal actions of nociceptin/orphanin FQ, morphine and substance P in regulating pain and itch in non-human primatesBr J Pharmacol2015172133302331225752320
  • KoMCNaughtonNNAntinociceptive effects of nociceptin/orphanin FQ administered intrathecally in monkeysJ Pain200910550951619231294
  • KalsoESodium channel blockers in neuropathic painCurr Pharm Des200511233005301116178759
  • BhattacharyaAWickendenADChaplanSRSodium channel blockers for the treatment of neuropathic painNeurotherapeutics20096466367819789071
  • DrayANeuropathic pain: emerging treatmentsBr J Anaesth20081011485818511441
  • BrochuRMDickIETarpleyJWBlock of peripheral nerve sodium channels selectively inhibits features of neuropathic pain in ratsMol Pharmacol200669382383216301337
  • EisensteinMNeuropathy: a name for their painNature20165357611S10S1127410524
  • Le PichonCECheslerATThe functional and anatomical dissection of somatosensory subpopulations using mouse geneticsFront Neuroanat201482124795573
  • BenarrochEEIon channels in nociceptors: recent developmentsNeurology201584111153116425713000